Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
-2.8%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$14.4B
AUM Growth
+$889M
(+6.6%)
Cap. Flow
-$1.97B
Cap. Flow
% of AUM
-13.71%
Top 10 Holdings %
Top 10 Hldgs %
26.05%
Holding
2,715
New
108
Increased
571
Reduced
304
Closed
146
Top Buys
| 1 |
Cheniere Energy
LNG
|
+$151M |
| 2 |
Marathon Petroleum
MPC
|
+$147M |
| 3 |
AbbVie
ABBV
|
+$143M |
| 4 |
Valero Energy
VLO
|
+$140M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$135M |
Top Sells
| 1 |
General Dynamics
GD
|
+$133M |
| 2 |
Kroger
KR
|
+$114M |
| 3 |
Cencora
COR
|
+$97.2M |
| 4 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$54.8M |
| 5 |
Penske Automotive Group
PAG
|
+$53.3M |
Sector Composition
| 1 | Energy | 14.73% |
| 2 | Healthcare | 13.68% |
| 3 | Technology | 9.71% |
| 4 | Materials | 9.15% |
| 5 | Real Estate | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Southern Company
SO
$101B
| $676K | ﹤0.01% |
9,936
-115,844
| -92% | -$7.88M |
|
527
Visa
V
$656B
| $674K | ﹤0.01% |
3,792
+905
| +31% | +$161K |
|
528
Repligen
RGEN
$6.76B
| $671K | ﹤0.01% |
3,587
+3,210
| +851% | +$600K |
|
529
Duke Energy
DUK
$94.4B
| $670K | ﹤0.01% |
7,205
-82,181
| -92% | -$7.64M |
|
530
Stryker
SYK
$146B
| $666K | ﹤0.01% |
3,286
+42
| +1% | +$8.51K |
|
531
Baidu
BIDU
$37B
| $656K | ﹤0.01% |
5,587
-838
| -13% | -$98.4K |
|
532
Paylocity
PCTY
$9.34B
| $653K | ﹤0.01% |
+2,701
| New | +$653K |
|
533
Boston Scientific
BSX
$156B
| $648K | ﹤0.01% |
16,744
-1,275
| -7% | -$49.3K |
|
534
DaVita
DVA
$9.46B
| $648K | ﹤0.01% |
7,829
+1,441
| +23% | +$119K |
|
535
Simon Property Group
SPG
$58.5B
| $640K | ﹤0.01% |
7,132
+6,610
| +1,266% | +$593K |
|
536
Becton Dickinson
BDX
$54B
| $635K | ﹤0.01% |
2,850
-31,446
| -92% | -$7.01M |
|
537
IQVIA
IQV
$31.3B
| $632K | ﹤0.01% |
3,487
+88
| +3% | +$16K |
|
538
JPMorgan Chase
JPM
$826B
| $625K | ﹤0.01% |
5,979
-44,366
| -88% | -$4.64M |
|
539
ResMed
RMD
$39.6B
| $620K | ﹤0.01% |
2,838
-206
| -7% | -$45K |
|
540
Edwards Lifesciences
EW
$46B
| $614K | ﹤0.01% |
7,425
+134
| +2% | +$11.1K |
|
541
Centene
CNC
$15.4B
| $597K | ﹤0.01% |
7,677
-20,508
| -73% | -$1.59M |
|
542
Zimmer Biomet
ZBH
$20.3B
| $591K | ﹤0.01% |
5,653
+78
| +1% | +$8.16K |
|
543
Bio-Rad Laboratories Class A
BIO
$7.49B
| $584K | ﹤0.01% |
1,399
+90
| +7% | +$37.6K |
|
544
Labcorp
LH
$22.7B
| $582K | ﹤0.01% |
3,310
-2,799
| -46% | -$492K |
|
545
West Pharmaceutical
WST
$18.4B
| $582K | ﹤0.01% |
2,366
+58
| +3% | +$14.3K |
|
546
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $576K | ﹤0.01% |
8,065
| – | – |
|
547
Waters Corp
WAT
$17.4B
| $576K | ﹤0.01% |
2,136
+136
| +7% | +$36.7K |
|
548
AES
AES
$9.06B
| $574K | ﹤0.01% |
25,410
+24,347
| +2,290% | +$550K |
|
549
Incyte
INCY
$16.8B
| $574K | ﹤0.01% |
8,611
-110
| -1% | -$7.33K |
|
550
SPDR Bloomberg High Yield Bond ETF
JNK
$8.1B
| $574K | ﹤0.01% |
6,533
| – | – |
|